LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway

Radiation resistance poses a major clinical challenge in breast cancer (BC) treatment, but little is known about how long noncoding RNA (lncRNA) may regulate this phenomenon. Here, we reported that DUXAP8 was highly expressed in radioresistant BC tissues, and high expression of DUXAP8 was associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Changjiang, Li, Shaoting, Fan, Ying, Hua, Li, Pan, Qingyun, Li, Yuan, Long, Zhixiong, Yang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635553/
https://www.ncbi.nlm.nih.gov/pubmed/36329030
http://dx.doi.org/10.1080/15384047.2022.2132008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635553/
https://www.ncbi.nlm.nih.gov/pubmed/36329030
http://dx.doi.org/10.1080/15384047.2022.2132008

Ejemplares similares